Matrix metalloproteinases are associated with severity of disease among COVID‐19 patients: A possible pharmacological target

Documenti analoghi

• Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions
  di: Nishit Joshi, et al.
  Pubblicazione: (2024)
• A novel approach combining network pharmacology and experimental validation to study the protective effect of ginsenoside Rb1 against cantharidin‐induced hepatotoxicity in mice
  di: Lijuan Xiong, et al.
  Pubblicazione: (2024)
• Copper: From enigma to therapeutic target for neurological disorder
  di: Jayant Patwa, et al.
  Pubblicazione: (2024)
• Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease
  di: Maartje M. van de Meeberg, et al.
  Pubblicazione: (2024)
• Perineuronal nets as regulators of parvalbumin interneuron function: Factors implicated in their formation and degradation
  di: Thamyris Santos‐Silva, et al.
  Pubblicazione: (2024)